Cell-Based Flu Antigen to Be Incorporated in DelSite's Nasal Vaccine Product DelSite is developing a nasal powder vaccine for pandemic avian influenza that combines its proprietary GelVac(TM) vaccine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback